Evidence map›Paper›PMID 37083592›Full record

ArticleJMIR research protocols2023

The Pharmacoeconomic Impact of Pharmaceutical Care in the Hospital: Protocol for an Overview of Systematic Reviews.

Fábio Jorge Ramalho de Amorim, Fernanda Valença-Feitosa, Marcos Cardoso Rios, Carlos Adriano Santos Souza, Izadora Menezes da Cunha Barros, Alfredo Dias de Oliveira-Filho, Divaldo Pereira de Lyra-Júnior

Open access · goldAbstract read
In one paragraph

Article in JMIR research protocols, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Fábio Jorge Ramalho de Amorim *Pharmacy Department, Laboratory of Teaching and Research in Social Pharmacy, Federal University of Sergipe, São Cristóvão, Brazil.ORCID https://orcid.org/0000-0001-6985-7836
Fernanda Valença-Feitosa *Pharmacy Department, Laboratory of Teaching and Research in Social Pharmacy, Federal University of Sergipe, São Cristóvão, Brazil.ORCID https://orcid.org/0000-0002-8777-4919
Marcos Cardoso Rios *Pharmacy Department, Laboratory of Teaching and Research in Social Pharmacy, Federal University of Sergipe, São Cristóvão, Brazil.ORCID https://orcid.org/0000-0002-3563-1756
Carlos Adriano Santos Souza *University Center AGES, Paripiranga, Brazil.ORCID https://orcid.org/0000-0002-7913-2510
Izadora Menezes da Cunha Barros *Pharmacy Department, Federal University of Sergipe, Campus Lagarto, Lagarto, Brazil.ORCID https://orcid.org/0000-0002-2624-9635
Alfredo Dias de Oliveira-Filho *Pharmacy Department, Laboratory of Teaching and Research in Social Pharmacy, Federal University of Sergipe, São Cristóvão, Brazil.ORCID https://orcid.org/0000-0003-3192-8285
Divaldo Pereira de Lyra-Júnior *Pharmacy Department, Laboratory of Teaching and Research in Social Pharmacy, Federal University of Sergipe, São Cristóvão, Brazil.ORCID https://orcid.org/0000-0002-0266-0702
Universidade Federal de Sergipe · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe clinical activities developed by pharmacists in a hospital environment can improve health outcomes and generate savings for hospitals. However, to determine whether pharmaceutical interventions are cost effective, it is essential to define a method according to which cost-effectiveness is intended to be measured. In addition, the quality of economic assessments and the amount of information present in systematic reviews in the literature make it difficult to analyze the effects of this intervention.

objectiveThis paper aims to provide an overview of systematic reviews on the pharmacoeconomic impact of the performance of pharmaceutical care in hospitals.

methodsA systematic search of the Cochrane Library databases, PubMed or MEDLINE, LILACS, Scopus, Web of Science, Google Scholar, and Open Thesis will be performed using the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement. The search will involve the use of keywords determined using the Medical Subject Headings database to define the search terms and include the following terms: "pharmacoeconomics," "pharmaceutical care," and "hospital." The study designs to be included will be systematic reviews of good quality. Studies will be included that address pharmacoeconomics; studies that evaluated pharmaceutical care in hospitals; and studies published in Portuguese, English, or Spanish. The primary outcome sought in the systematic reviews will be the cost ratio in monetary units and the outcomes in monetary or natural units. The secondary economic outcomes considered will be determined based on factors associated with the drugs and translated into benefit, efficacy, or utility.

resultsIt is intended to start this overview in January 2023. Thus far, only previous searches have been carried out to contextualize the theme and build the protocol.

conclusionsThis overview will determine the pharmacoeconomic impact of pharmaceutical care interventions in the hospital environment. In addition, this study will point out which clinical outcomes in natural units are impacted by the performance of pharmaceutical care and the strengths and limitations of each approach. It will also identify gaps in the literature and areas for future work.

trial registrationPROSPERO CRD42019140665; https://tinyurl.com/bddwnz43.

Indexed as

cost benefitcost-effectivenesscost-utilityhospitaloverviewpharmaceutical carepharmacoeconomics

Identifiers

PMID37083592
PMCPMC10163400
OpenAlexW4366602804

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.